Proto Script Pharmaceutical Corp.
PSCR · OTC
12/31/2016 | 12/31/2015 | 5/31/2014 | 5/31/2013 | |
|---|---|---|---|---|
| Market Cap | $88 | $9 | $9 | $9 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $88 | $9 | $9 | $9 |
| Revenue | $1 | $1 | $0 | $0 |
| % Growth | -10.5% | – | – | – |
| Gross Profit | $1 | $1 | $0 | $0 |
| % Margin | 71.5% | 78.8% | – | – |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -37.1% | -8% | – | – |
| Net Income | -$7 | -$0 | -$0 | -$0 |
| % Margin | -910.4% | -16.5% | – | – |
| EPS Diluted | -0.077 | -0.005 | -0.001 | -0.001 |
| % Growth | -1,493.8% | -269.2% | -18.2% | – |
| Operating Cash Flow | $0 | $0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | $0 | $0 |
| Free Cash Flow | $0 | $0 | -$0 | -$0 |